Mass. Eye and Ear makes history, injecting $850,000 gene therapy for first time

Philadelphia-based biotech Spark Therapeutics made history in December by winning FDA approval for the first gene therapy for an inherited disease. Now, Massachusetts Eye and Ear says it has performed the first post-approval injection of the drug, which treats a form of blindness and costs $850,000. The hospital announced on Tuesday that Jason Comander, the associate director of its inherited retinal disorders service, had performed the procedure on a 13-year-old boy from New Jersey. He is the first…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news